POSTER 9
- Kelley Tangredi
- Jun 22, 2025
- 1 min read
Updated: Jul 2, 2025
Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata (AA): 3-Year Results from the ALLEGRO-LT Phase 3, Open-Label Study
Maryanne Senna, Ignasi Figueras, Misaki Kinoshita-Ise, Sameh Hanna, Wenyu Wu, Dalia Wajsbrot, Deborah Woodworth, Robert Wolk, Alanna Chaudhry, Alex Lejeune, Helen Tran
< Previous Poster | Next Poster >


